Finance

Lists
Why is TCRX up ११.११%?
Dive Deeper
TCRX:NASDAQ
Tscan Therapeutics Inc
US$ ०.२१
+११.११%
(+०.०२१) 1D
US$ ०.२१
-०.४८% (-०.००१००)
Pre-market
Closed: नोभेम्बर ४, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TCRX...
Open
US$ ०.२०
High
US$ ०.२१
Low
US$ ०.१९
Mkt. cap
१.४२ करोड
Avg. vol.
५.६४ लाख
Volume
०.००
52-wk high
US$ १.४७
52-wk low
US$ ०.१७
EPS
-US$ ०.९१
Beta
१.२१
Shares outstanding
६.३५ करोड
No. of employees
१३८
Open
US$ ०.२०
High
US$ ०.२१
Low
US$ ०.१९
Mkt. cap
१.४२ करोड
Avg. vol.
५.६४ लाख
Volume
०.००
52-wk high
US$ १.४७
52-wk low
US$ ०.१७
EPS
-US$ ०.९१
Beta
१.२१
Shares outstanding
६.३५ करोड
No. of employees
१३८
News stories
From web sources and news partners
Reuters Connect
Reuters Connect
·
३ मिनेट पहिले
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City
Columbus Ledger-Enquirer
Columbus Ledger-Enquirer
·
५४ मिनेट पहिले
S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
Yahoo Finance
Yahoo Finance
·
५० मिनेट पहिले
Invesco NASDAQ 100 ETF (QQQM) Adds NVIDIA and Apple on Tuesday
CNN
CNN
·
२२ घण्टा पहिले
CVS to split into two companies, in major breakup of its $117 billion healthcare empire
About Tscan Therapeutics Inc
CEO-
Employees१३८
Founded२०१८
HeadquartersWaltham, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Industry-
Websitetscan.com
Analyst ratings
Based on 6 analysts giving stock ratings to TCRX in the past 3 months
Hold
Buy
1
Hold
5
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TCRX in the last 3 months.
Highest
Current US$ ०.२१
US$ १.०० (+३७६.१९%)
Average
US$ १.०० (+३७६.१९%)
Lowest
US$ १.०० (+३७६.१९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Hold
Downgraded
US$ १.००
+३७६.२%
09/09/2026
Sam Slutsky
LifeSci Capital
Hold
Downgraded
-
-
09/02/2026
Gil Blum
Needham
Hold
Downgraded
-
-
09/02/2026
David Nierengarten
Wedbush
Hold
Downgraded
US$ १.००
+३७६.२%
09/03/2026
Maxwell Skor
Morgan Stanley
Hold
Maintained
-
-
08/17/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
08/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२५.११ लाख
२५.६७ लाख
९.८२ लाख
१०.५१ लाख
Cost of goods sold
३.१७ करोड
१.८४ करोड
२.१९ करोड
२.३४ करोड
Cost of revenue
३.१७ करोड
१.८४ करोड
२.१९ करोड
२.३४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७८.७४ लाख
५९.८६ लाख
८२.१७ लाख
८१.४२ लाख
Operating expense
७८.७४ लाख
५९.८६ लाख
८२.१७ लाख
८१.४२ लाख
Total operating expenses
३.९६ करोड
२.४४ करोड
३.०१ करोड
३.१५ करोड
Operating income
-३.७१ करोड
-२.१९ करोड
-२.९१ करोड
-३.०५ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-३.५७ करोड
-२.३० करोड
-२.८७ करोड
-३.०४ करोड
EBT excluding unusual items
-३.५७ करोड
-२.१० करोड
-२.८७ करोड
-३.०४ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३.५७ करोड
-२.३० करोड
-२.८७ करोड
-३.०४ करोड
Net profit margin
-१,४२२.१४%
-८९५.०९%
-२,९१९.१४%
-२,८८८.५८%
Earnings per share
-०.२८
-०.१८
-०.२२
-०.२३
Interest and investment income
२०.४१ लाख
१५.८३ लाख
११.६२ लाख
८.३३ लाख
Interest expense
-६.९९ लाख
-७.०२ लाख
-६.८९ लाख
-६.९९ लाख
Net interest expenses
१३.४२ लाख
८.८१ लाख
४.७३ लाख
१.३४ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३.६३ करोड
-२.११ करोड
-२.८४ करोड
-२.९८ करोड
Gain or loss from assets sale
-
-
-
९९.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू